|
Recent Newsletters
Interventional Cardiology: IVL's new reimbursement rate | FDA approves 2 RDN systems | Catheter kits recalled |
News Alert: FDA approves another renal denervation system for hypertension |
Gene-editing therapy for heart patients impresses | Prosthesis-patient mismatch & TAVR: A new perspective |
The future of cardiology | A brand new way to evaluate heart risks | CVD deaths on the rise | More from the last week |
A warning about TAVR | Trends in care for the tricuspid & mitral valves | Accurate AI | PE funds deal for stroke drug |
TAVR or SAVR? | Cardiology groups push for changes that could prevent Medicare cuts | A reimbursement update |
Unnecessary stents | Good news for Edwards | TAVR triumphs | Portfolio diet reduces risks | More from the last week |